Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable 3-29 (pseudogene) (IGLV3-29)
- Target
- IGLV3-29
- Molecular classification
- Other (pseudogene), Immunoglobulin variable region family member
01
Overview
Immunoglobulin lambda variable 3-29 is a member of the immunoglobulin lambda variable region gene family. However, IGLV3-29 is classified as a pseudogene in humans, meaning it does not encode a functional protein. Immunoglobulin variable region genes typically contribute to the diversity of binding sites in antibodies, facilitating immune recognition of antigens. Pseudogenes such as IGLV3-29 are non-functional due to sequence variations, deletions, or lack of regulatory elements required for transcription or translation, and therefore do not play a direct role in immunity or serve as drug targets[5][4].
- Other names
- IGLV329
02
Mechanism of action
None (no mechanism of drug action is applicable)
03
Biological functions
None (being a pseudogene, it does not participate in biological functions related to signal transduction, immune response or cell cycle directly)
04
Disease associations
None (no direct disease association due to lack of functional expression)
Beyond the preview
Go deeper on Immunoglobulin lambda variable 3-29 (pseudogene) (IGLV3-29).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunoglobulin lambda variable 3-29 (pseudogene) (IGLV3-29).